Medical materials

Publication
  • EBMT •
  • 23 March, 2026 •
  • •

Emapalumab is associated with Rapid and Sustained Benefits in pHLH Subgroups, Including CNS Involvement and Previously Untreated Patients: Analysis of trials NI-0501-04, NI-050105 and NI-050109

Franco Locatelli, Michael B. Jordan, Didier Halimi, Elena Burillo, Brian D. Jamieson, Emmanuel Monnet, Andrew Danquah

Publication
  • EBMT •
  • 23 March, 2026 •
  • •

Emapalumab induces rapid, durable responses and reliable bridging to curative HSCT in patients with primary HLH: Pooled analysis of prospective trials NI-0501-04, NI-0501-05 and NI-0501-09

Michael B. Jordan, Franco Locatelli, Didier Halimi, Elena Burillo, Brian D. Jamieson, Andrew Danquah, Emmanuel Monnet

Sign up for alerts